RUNX2 and breast carcinoma: Work on well-characterised breast cancer cell lines has shown that RUNX2 can influence the behaviour of these cells and the response of host tissues following orthotopic injection to bone (Barnes et al., 2004; Javed et al., 2005; Pratap et al., 2008), but this work has been limited to a few cell lines.